Health Care Equipment

Evome Medical Technologies Inc.

Evome Medical Technologies Inc. released FY2024 9 Months Earnings on November 25 (EST), with actual revenue of 22.76 M USD and EPS of -0.0644 USD

Evome Medical Technologies Inc. released FY2024 Q3 earnings on November 25 (EST), actual revenue USD 7.406 M, actual EPS USD -0.0093

Evome Medical Technologies Inc. released FY2023 Cumulative 3Q Earnings on November 14 Pre-Market (EST), with actual revenue of 33.98M USD and EPS of -0.0034

Evome Medical Technologies Inc. released FY2023 Q3 earnings on November 14 Pre-Market EST, with actual revenue of USD 14.63 M and EPS of USD 0.0285

A SPAC III Acquisition

PicoCELA

Davis Commodities

Society Pass

ECD Automotive Design

Gauzy

Bristol-Myers Squibb Company

A SPAC III ACQUISITION CORP. COM NPV CL A (SUBS/RTS)02/01/2026

Paranovus ENT Tech

Cue BioPharma

Delcath

Electromed

雅培

直觉外科

波士顿科学

史赛克

IDEXX实验室

爱德华生命科学

瑞思迈

德康医疗

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap